[go: up one dir, main page]

DE69028884D1 - Protein mit Urate-Oxidase-Aktivität, dafür kodierendes rekombinantes Gen, Expressionsvektor, Mikroorganismen und Transformanten - Google Patents

Protein mit Urate-Oxidase-Aktivität, dafür kodierendes rekombinantes Gen, Expressionsvektor, Mikroorganismen und Transformanten

Info

Publication number
DE69028884D1
DE69028884D1 DE69028884T DE69028884T DE69028884D1 DE 69028884 D1 DE69028884 D1 DE 69028884D1 DE 69028884 T DE69028884 T DE 69028884T DE 69028884 T DE69028884 T DE 69028884T DE 69028884 D1 DE69028884 D1 DE 69028884D1
Authority
DE
Germany
Prior art keywords
protein
oxidase activity
transformants
microorganisms
expression vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69028884T
Other languages
English (en)
Other versions
DE69028884T2 (de
Inventor
Daniel Caput
Pascual Ferrara
Jean Claude Guillemot
Mourad Kaghad
Richard Legoux
Gerard Loison
Elizabeth Larbre
Johannes Lupker
Pascal Leplatois
Marc Salome
Patrick Laurent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8909550A external-priority patent/FR2649720A1/fr
Priority claimed from FR8917466A external-priority patent/FR2656530B1/fr
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of DE69028884D1 publication Critical patent/DE69028884D1/de
Publication of DE69028884T2 publication Critical patent/DE69028884T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0044—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7)
    • C12N9/0046—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7) with oxygen as acceptor (1.7.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Saccharide Compounds (AREA)
  • Glass Compositions (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
DE69028884T 1989-07-13 1990-07-13 Protein mit Urate-Oxidase-Aktivität, dafür kodierendes rekombinantes Gen, Expressionsvektor, Mikroorganismen und Transformanten Expired - Lifetime DE69028884T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8909550A FR2649720A1 (en) 1989-07-13 1989-07-13 Recombinant gene which encodes a protein such as urate oxidase
FR8917466A FR2656530B1 (fr) 1989-12-29 1989-12-29 Gene recombinant pour une expression dans les cellules eucaryotes d'une proteine telle que l'urate oxydase.
FR9001368A FR2657785A2 (fr) 1989-12-29 1990-02-06 Gene recombinant pour une expression dans les cellules animales d'une proteine telle que l'urate oxydage.

Publications (2)

Publication Number Publication Date
DE69028884D1 true DE69028884D1 (de) 1996-11-21
DE69028884T2 DE69028884T2 (de) 1997-05-07

Family

ID=27251947

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2001199042 Active DE10199042I2 (de) 1989-07-13 1990-07-13 Protein mit Urate-Oxidase-Aktivit{t daf}r kodierendes rekombinantes Gen Expressionsvektor Mikroorganismen und Transformanten
DE69028884T Expired - Lifetime DE69028884T2 (de) 1989-07-13 1990-07-13 Protein mit Urate-Oxidase-Aktivität, dafür kodierendes rekombinantes Gen, Expressionsvektor, Mikroorganismen und Transformanten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE2001199042 Active DE10199042I2 (de) 1989-07-13 1990-07-13 Protein mit Urate-Oxidase-Aktivit{t daf}r kodierendes rekombinantes Gen Expressionsvektor Mikroorganismen und Transformanten

Country Status (23)

Country Link
EP (1) EP0408461B1 (de)
JP (1) JP2664804B2 (de)
AT (1) ATE144282T1 (de)
AU (1) AU636637B2 (de)
BR (1) BR9006855A (de)
CA (1) CA2035900C (de)
DE (2) DE10199042I2 (de)
DK (1) DK0408461T3 (de)
ES (1) ES2095243T3 (de)
FI (1) FI105047B (de)
GR (1) GR3022085T3 (de)
HU (1) HU215948B (de)
IE (1) IE77158B1 (de)
IL (1) IL95057A (de)
LU (1) LU90781I2 (de)
LV (1) LV12000B (de)
MC (1) MC2145A1 (de)
NL (1) NL300046I2 (de)
NO (1) NO2001018I2 (de)
NZ (1) NZ234453A (de)
PT (1) PT94680B (de)
RU (1) RU2105812C1 (de)
WO (1) WO1991000909A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2971218B2 (ja) * 1991-12-04 1999-11-02 協和醗酵工業株式会社 ウリカーゼ遺伝子およびウリカーゼの製造法
US5691188A (en) 1994-02-14 1997-11-25 American Cyanamid Company Transformed yeast cells expressing heterologous G-protein coupled receptor
CN1268741C (zh) * 1996-09-13 2006-08-09 超卡里奥迪克治疗学股份有限公司 半乳糖苷酶a缺乏症的治疗
US6083725A (en) 1996-09-13 2000-07-04 Transkaryotic Therapies, Inc. Tranfected human cells expressing human α-galactosidase A protein
US6783965B1 (en) * 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
PL202799B1 (pl) * 1998-08-06 2009-07-31 Mountain View Pharmaceuticals Sposób izolowania urykazy w postaci tetramerycznej oraz wyizolowana tetrameryczna urykaza
EP2316475B1 (de) 1998-08-06 2017-10-04 Mountain View Pharmaceuticals, Inc. Isolierte tetramere Uricase
EP1310560A4 (de) 2000-08-17 2005-07-13 Ajinomoto Kk Verfahren zur veranderung von transglutaminase aus mikroorganismen
AU2003228722B2 (en) 2002-04-25 2009-06-25 Takeda Pharmaceutical Company Limited Treatment of alpha-galactosidase A deficiency
TW200716751A (en) 2005-04-11 2007-05-01 Savient Pharmaceuticals Inc A variant form of urate oxidase and use thereof
TWI418564B (zh) * 2005-04-11 2013-12-11 Savient Pharmaceuticals Inc 利用陽離子界面活性劑之蛋白質純化
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
PL3321359T3 (pl) 2005-04-11 2021-06-28 Horizon Pharma Rheumatology Llc Wariantowe postacie oksydazy moczanowej i ich zastosowanie
EP2013225B1 (de) 2006-04-12 2014-12-17 Crealta Pharmaceuticals LLC Proteinaufreiningung mit hilfe von kationischen tensiden
RU2443426C2 (ru) * 2008-11-07 2012-02-27 Мунтэн Вью Фармасьютикэлз, Инк. Конъюгаты уратоксидазы, фармацевтическая композиция для снижения уровней мочевой кислоты и способ получения вышеупомянутых конъюгатов
PL398781A1 (pl) 2009-06-25 2012-11-19 Savient Pharmaceuticals, Inc. Sposoby i zestawy do prognozowania ryzyka wystapienia reakcji na wlew oraz zaniku odpowiedzi której posrednicza przeciwciala poprzez monitorowanie kwasu moczowego w surowicy podczas terapii z zastosowaniem pegylowanej urykazy
EP3538135A4 (de) 2016-11-11 2020-07-29 Horizon Pharma Rheumatology LLC Kombinationstherapien von prednison- und uricase-molekülen und deren verwendung
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
CN109223707B (zh) * 2018-09-13 2020-12-08 中国药科大学 一种尿酸酶外用凝胶制剂、其制备方法及用途
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6301M (de) * 1967-03-29 1968-09-09
SU457723A1 (ru) * 1973-04-09 1977-08-05 Всесоюзный Научно-Исследовательский Витаминный Институт Штамм 313-152 - продуцент уратоксидазы
EP0423890A3 (en) * 1984-07-27 1991-07-03 Unilever Nv Use of oxidoreductases in bleaching and/or detergent compositions and their preparation by microorganisms engineered by recombinant dna technology
WO1988008450A1 (en) * 1987-05-01 1988-11-03 Birdwell Finlayson Gene therapy for metabolite disorders
JPH0671428B2 (ja) * 1988-08-17 1994-09-14 サッポロビール株式会社 ウリカーゼのｄｎａ配列および製法

Also Published As

Publication number Publication date
AU6052390A (en) 1991-02-06
EP0408461B1 (de) 1996-10-16
DE10199042I1 (de) 2002-01-10
ATE144282T1 (de) 1996-11-15
LV12000B (lv) 1998-06-20
IL95057A0 (en) 1991-06-10
LU90781I2 (fr) 2001-07-23
LV12000A (lv) 1998-03-20
GR3022085T3 (en) 1997-03-31
JPH04501807A (ja) 1992-04-02
EP0408461A1 (de) 1991-01-16
PT94680A (pt) 1991-04-18
FI105047B (fi) 2000-05-31
HK1000099A1 (en) 1997-11-21
DE69028884T2 (de) 1997-05-07
DE10199042I2 (de) 2003-10-23
BR9006855A (pt) 1991-08-06
CA2035900C (fr) 2000-01-11
ES2095243T3 (es) 1997-02-16
PT94680B (pt) 1997-04-30
JP2664804B2 (ja) 1997-10-22
HU215948B (hu) 1999-03-29
MC2145A1 (fr) 1992-02-18
DK0408461T3 (da) 1997-03-24
AU636637B2 (en) 1993-05-06
IE902559A1 (en) 1991-02-27
FI911212A0 (fi) 1991-03-12
NL300046I1 (nl) 2001-09-03
RU2105812C1 (ru) 1998-02-27
CA2035900A1 (fr) 1991-01-14
WO1991000909A1 (fr) 1991-01-24
NZ234453A (en) 1993-01-27
NL300046I2 (nl) 2001-12-01
NO2001018I2 (no) 2006-05-01
HU906046D0 (en) 1991-07-29
IL95057A (en) 1997-07-13
IE77158B1 (en) 1997-12-03
HUT56884A (en) 1991-10-28

Similar Documents

Publication Publication Date Title
DE10199042I1 (de) Protein mit Urate-Oxidase-Aktivitaet dafuer kodierendes rekombinantes Gen Expressionsvektor Mikroorganismen und Transformanten
DE59812730D1 (de) Mikroorganismen und Verfahren zur fermentativen Herstellung von L-Cystein, L-Cystin, N-Acetyl-Serin oder Thiazolindinderivaten
DK1003379T3 (da) Hidtil ukendt phytase
NO20024945D0 (no) Ekspresjonsregulerende sekvenser og ekspresjonsprodukter
ATE153069T1 (de) Vektoren und zusammensetzungen zur expression von glykosilationsmutanten des menschlichen proteins- c
NO177863C (no) Fremgangsmåte for fremstilling av rekombinant humant IFN-type I, IFN1, IFN-pseudo-2, -3, og -4, samt ekspresjonsvektorer
ES2124694T3 (es) Clonacion de la n-metil-hidantoinasa.
ATE139571T1 (de) Rekombinante dna-expressionsvektoren und dna- zusammensetzungen, die isopenizillin n-epimerase- aktivität kodieren
ATE120491T1 (de) Ausgeglichenes, konstitutives, induzierbares transkriptionssystem.
EP0302838A3 (en) Cloning of the gene coding the isoamylase enzyme and its use in the production of said enzyme
ATE297993T1 (de) Cytochrom p450 gen
DE59109126D1 (de) N-Carbamoylsarcosin-Amidohydrolase, kloniert
ATE154074T1 (de) Verfahren zur herstellung und reinigung des carboxyterminalen fragments der dna-polymerase i von streptococcus pneumoniae
JPS6443194A (en) Plasmid and escherichia-coli transformed therewith